Rua Bioscience burns through $6.2m

Rua Bioscience burns through $6.2m
Rua: R&D spending up. (Image: Supplied)
Brent Melville
Listed medicinal cannabis firm Rua Bioscience almost doubled its cash burn rate for the year to June, recording a loss before tax of $6.17 million, from a loss of $3.59m last year.That was after research and development spending jumped to $1.9m, from $1.29m in 2020, reflecting the costs of developing the firm’s product lines, and investment into cultivation and manufacturing. The East Coast-based firm’s income came in the form of a government research and development grant of $357,366 and a covid wage subsidy of $91,636. It emp...

More Markets

NZX lifts 0.2% as markets wait for US Fed decision
Markets Market Close

NZX lifts 0.2% as markets wait for US Fed decision

The S&P/NZX 50 gained 0.2% to 13,234.89 points on Tuesday.

Oceania forecasts sales lift as it targets debt
Property

Oceania forecasts sales lift as it targets debt

It said sales applications had lifted 23% between July and August.

New structure, powers for ComCom
Markets

New structure, powers for ComCom

Groceries, aviation, building supplies, digital services carparking all get a mention.

NZME shareholder Jim Grenon lifts investment in media firm
Markets

NZME shareholder Jim Grenon lifts investment in media firm

NZME shareholder and director Jim Grenon has lifted his investment in the media business for the second time in recent weeks, to just under 18%.A notice to the NZX on Monday stated Grenon had lifted his shareholding from 15.963% to 17.932%, after acquiring 3.7 million shares for...